US FDA approves Gilead's COVID-19 drug for young children
April 26, 2022 at 09:38 AM EDT
The FDA has granted full approval to Gilead's remdesivir COVID-19 treatment for children 28 days and older.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|